We found that some eRNA targets were known cancer genes relevant to tumor immunity, including MLXIPL, MPL, RAF1, and XPC. RAF1 was annotated as an oncogene and participated in the RTK-RAS signaling pathway (Figure 4A), and MLXIPL was involved in MYC signaling pathway (Figure 4B). This evidence concerns the gene MPL and neoplasm.